These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 378855)
41. Characterization of the immunoprotective antigen of ribosomal preparations from Haemophilus influenzae. Tewari RP; Lynn M; Birnbaum AJ; Solotorovsky M Infect Immun; 1978 Jan; 19(1):58-65. PubMed ID: 304844 [TBL] [Abstract][Full Text] [Related]
42. A 5-year study of the seroepidemiology of Klebsiella pneumoniae: high prevalence of capsular serotype K1 in Taiwan and implication for vaccine efficacy. Fung CP; Hu BS; Chang FY; Lee SC; Kuo BI; Ho M; Siu LK; Liu CY J Infect Dis; 2000 Jun; 181(6):2075-9. PubMed ID: 10837197 [TBL] [Abstract][Full Text] [Related]
43. [Analysis of immunoprotection against fatal experimental Klebsiella pneumoniae pneumonia]. Shimoguchi K Kansenshogaku Zasshi; 1990 Dec; 64(12):1482-92. PubMed ID: 2074365 [TBL] [Abstract][Full Text] [Related]
44. Passive immunization of mice against Klebsiella aerogenes. Roe EA; Jones RJ; Dyster RE Br J Exp Pathol; 1986 Feb; 67(1):25-32. PubMed ID: 3511939 [TBL] [Abstract][Full Text] [Related]
45. Development of a Colloidal Gold-Based Immunochromatographic Strip for Rapid Detection of Klebsiella pneumoniae Serotypes K1 and K2. Siu LK; Tsai YK; Lin JC; Chen TL; Fung CP; Chang FY J Clin Microbiol; 2016 Dec; 54(12):3018-3021. PubMed ID: 27707941 [TBL] [Abstract][Full Text] [Related]
46. Capsular Polysaccharide Is Involved in NLRP3 Inflammasome Activation by Klebsiella pneumoniae Serotype K1. Hua KF; Yang FL; Chiu HW; Chou JC; Dong WC; Lin CN; Lin CY; Wang JT; Li LH; Chiu HW; Chiu YC; Wu SH Infect Immun; 2015 Sep; 83(9):3396-409. PubMed ID: 26077758 [TBL] [Abstract][Full Text] [Related]
47. Structural variation in the O-specific polysaccharides of Klebsiella pneumoniae serotype O1 and O8 lipopolysaccharide: evidence for clonal diversity in rfb genes. Kelly RF; Severn WB; Richards JC; Perry MB; MacLean LL; Tomás JM; Merino S; Whitfield C Mol Microbiol; 1993 Nov; 10(3):615-25. PubMed ID: 7526122 [TBL] [Abstract][Full Text] [Related]
48. Role of interferon in mice in protection against influenza A virus by bacterial ribosomes together with membranal glycoproteins of Klebsiella pneumoniae as adjuvant. Robert D; Quillon JP; Ivanoff B; Beaudry Y; Fontanges R; Normier G; Pinel AM; D'hinterland LD Infect Immun; 1979 Nov; 26(2):515-9. PubMed ID: 94908 [TBL] [Abstract][Full Text] [Related]
49. Extracellular polysaccharide production by Klebsiella pneumoniae and its relationship to virulence. Domenico P; Diedrich DL; Straus DC Can J Microbiol; 1985 May; 31(5):472-8. PubMed ID: 3891056 [TBL] [Abstract][Full Text] [Related]
50. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma. Campbell WN; Hendrix E; Cryz S; Cross AS Clin Infect Dis; 1996 Jul; 23(1):179-81. PubMed ID: 8816151 [TBL] [Abstract][Full Text] [Related]
51. Humoral immunity to Streptococcus pneumoniae induced by a pneumococcal ribosomal protein fraction. Swendsen CL; Johnson W Infect Immun; 1976 Aug; 14(2):345-54. PubMed ID: 9362 [TBL] [Abstract][Full Text] [Related]
52. Vaccination against 77 capsular types of Klebsiella aerogenes with polyvalent Klebsiella vaccines. Jones RJ; Roe EA J Med Microbiol; 1984 Dec; 18(3):413-21. PubMed ID: 6389878 [TBL] [Abstract][Full Text] [Related]
53. A Staphylococcus aureus capsular polysaccharide (CP) vaccine and CP-specific antibodies protect mice against bacterial challenge. Fattom AI; Sarwar J; Ortiz A; Naso R Infect Immun; 1996 May; 64(5):1659-65. PubMed ID: 8613375 [TBL] [Abstract][Full Text] [Related]
54. [Nonharsh methods of isolation of antigenic complexes of Klebsiella pneumoniae, and analysis of their protective activity]. Egorova NB; Kurbatova EA; Miroshnichenko IV; Mashilova GM; Gladus MA Zh Mikrobiol Epidemiol Immunobiol; 1983 Feb; (2):96-101. PubMed ID: 6340397 [TBL] [Abstract][Full Text] [Related]
55. Genetic exchange of determinants for capsular polysaccharide biosynthesis between Klebsiella pneumoniae strains expressing serotypes K2 and K21a. Ofek I; Kabha K; Athamna A; Frankel G; Wozniak DJ; Hasty DL; Ohman DE Infect Immun; 1993 Oct; 61(10):4208-16. PubMed ID: 8104896 [TBL] [Abstract][Full Text] [Related]
57. Microbial adjuvant and autoimmunity. IV. Production of lesions in the exocrine pancreas of mice by repeated injection of syngeneic pancreatic extract together with the capsular polysaccharide of Klebsiella pneumoniae. Yamaki K; Ohta M; Nakashima I; Noda A; Asai J; Kato N Microbiol Immunol; 1980; 24(10):945-56. PubMed ID: 7007828 [TBL] [Abstract][Full Text] [Related]
58. Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumonia. Held TK; Trautmann M; Mielke ME; Neudeck H; Cryz SJ; Cross AS Infect Immun; 1992 May; 60(5):1771-8. PubMed ID: 1563764 [TBL] [Abstract][Full Text] [Related]
59. The role of capsular polysaccharide K21b of Klebsiella and of the structurally related colanic-acid polysaccharide of Escherichia coli in resistance to phagocytosis and serum killing. Allen PM; Fisher D; Saunders JR; Hart CA J Med Microbiol; 1987 Dec; 24(4):363-70. PubMed ID: 3320374 [TBL] [Abstract][Full Text] [Related]
60. Induction of resistance in mice by the capsular polysaccharide antigens of Staphylococcus aureus. Yoshida K; Umeda A; Ohshima Y Microbiol Immunol; 1987; 31(7):649-56. PubMed ID: 3125414 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]